Otonomy completes enrolment in Phase II trial of AuriPro in paediatric patients with AOMT
US-based biopharmaceutical firm Otonomy has completed enrolment in a Phase II clinical trial of AuriPro, a sustained-exposure formulation of the antibiotic ciprofloxacin, to treat paediatric patients with acute otitis media with tympanostomy tubes (A…
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news
More News: Cipro | Ciprofloxacin | Clinical Trials | Otitis | Otitis Media | Pediatrics | Pharmaceuticals